Developing a Discrimination Model to Diagnose ALS
BF
Overseen byBradley Foerster, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Michigan
No Placebo Group
Approved in 1 Jurisdiction
Trial Summary
What is the purpose of this trial?
To combine several brain imaging techniques to develop a new diagnostic test to help with earlier diagnosis of amyotrophic lateral sclerosis.
Research Team
BF
Bradley Foerster, M.D.
Principal Investigator
University of Michigan Hospital
Eligibility Criteria
Inclusion Criteria
18 years of age or older
subjects with ALS (amyotrophic lateral sclerosis)
healthy subjects -
Treatment Details
Interventions
- MRI (Diagnostic Test)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Amyotrophic lateral sclerosisExperimental Treatment1 Intervention
Clinical examination for ALS(amyotrophic lateral sclerosis) and subjects with lower motor neuron signs will be completed. These subjects will undergo MRI (magnetic resonance imaging) scans of the brain to assess neurological conditions.
Group II: Healthy controls (MRI)Active Control1 Intervention
These subjects will undergo MRI (magnetic resonance imaging) scans of the brain to compare against diseased subjects.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Trials
1,891
Recruited
6,458,000+
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD